Ying Luo serves as Executive at GYRE THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Ying Luo has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 30, 2023 involved transacting 2,840,376 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 30, 2023 | GYRE | $0 | Other | 2,840,376 | $N/A | Discretionary |
Ying Luo currently holds 2,840,376 shares of GYRE THERAPEUTICS, INC. (GYRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ying Luo has been a net neutral trader of GYRE stock. They have purchased $0 and sold $0 worth of shares.
Ying Luo's most recent insider trade was on Oct 30, 2023, when they sold 2,840,376 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted